Filing Flows › Cumberland Pharmaceuticals (CPIX) › Who owns the stock
Who owns Cumberland Pharmaceuticals (CPIX) stock
34 funds reported Cumberland Pharmaceuticals (CPIX) shares in their latest 13F filings, worth $17.8M in all. The largest holder is Ikarian Capital, LLC ($3.3M). Last quarter 18 funds added to their stakes and 11 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Ikarian Capital, LLC | 503,153 | $3.3M | decrease | 2026-06-30 |
| Renaissance Technologies LLC | 478,263 | $3.1M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 379,478 | $2.5M | increase | 2026-06-30 |
| Vanguard Group | 411,786 | $1.6M | unchanged | 2025-12-31 |
| Dimensional Fund Advisors LP | 233,305 | $1.5M | decrease | 2026-06-30 |
| Boothbay Fund Management, LLC | 112,544 | $729K | decrease | 2026-06-30 |
| Geode Capital Management, LLC | 108,413 | $703K | decrease | 2026-06-30 |
| Perceptive Advisors LLC | 96,982 | $628K | decrease | 2026-06-30 |
| Citadel Advisors LLC | 73,391 | $476K | increase | 2026-06-30 |
| BlackRock | 63,547 | $412K | increase | 2026-06-30 |
| Bank of New York Mellon | 58,458 | $379K | unchanged | 2026-06-30 |
| Jane Street Group, LLC | 56,741 | $368K | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 54,909 | $356K | increase | 2026-06-30 |
| State Street | 39,510 | $256K | unchanged | 2026-06-30 |
| Bailard | 24,624 | $193K | unchanged | 2026-09-30 |
Cumberland Pharmaceuticals' latest quarter
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CPIX stock?
By the latest 13F filings: Ikarian Capital, LLC ($3.3M); Renaissance Technologies LLC ($3.1M); Vanguard Capital Management LLC ($2.5M); Vanguard Group ($1.6M); Dimensional Fund Advisors LP ($1.5M).
What is the short interest in CPIX?
336,001 shares were sold short at the 2026-10-15 settlement, -3.69% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.